Episurf Medical’s 100th Episealer® Femoral Twin implant demonstrates rapid clinical adoption
Episurf Medical (NASDAQ: EPIS B) announces the 100th implantation of the knee implant Episealer Femoral Twin, which together with Episealer Condyle Solo and Episealer Trochlea Solo constitute Episurf Medical’s product portfolio of patient-specific knee implants. This personalised treatment solution was developed to treat patients presenting with larger areas and an elongated nature of chondral and osteochondral damage of the femoral condyles and trochlea area of the knee. "According to theory, a knee in need of an Episealer Twin implant is often somewhat more damaged, possibly further